Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,250.00    -54.00 (-1.25%)
Bid:
4,226.00
Ask:
4,230.00
Spread: 4.00 (0.095%)
Market Cap: £4.46b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Director/PDMR Shareholding

7 Jun 2023 12:00

RNS Number : 9780B
Computacenter PLC
07 June 2023
 

 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

Computacenter plc

(the 'Company')

 

The following notifications are made under Article 19 of the Market Abuse Regulation ('MAR') relating to certain transactions in the shares of the Company by Chris Jehle, the Chief Financial Officer, Executive Director, and Person Discharging Managerial Responsibility of the Company ('PDMR').

 

Grant of Awards - Performance Share Plan

 

The Company announces that on 5 June 2023, in accordance with the rules of the Computacenter Performance Share Plan 2005 (the 'PSP'), the Company granted two awards:

- an award of nil-cost options (the '2023 PSP Award'); and

- a further award of nil-cost options (the 'Replacement PSP Award'),

(together, the 'PSP Awards') over Ordinary Shares of 75/9 pence each in the capital of the Company ('Ordinary Shares'), to the following Director and PDMR:

 

2023 PSP Award

Director

Number of shares awarded1

Mr M C Jehle (Director)

33,973

1 Calculated using a price of 2318 pence per Ordinary Share which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, over the period from 31 May 2023 to 2 June 2023, being the three trading days before the Date of Grant of the PSP Award. The award has a value of £787,500, which is 175% of Mr Jehle's current base salary.

 

No consideration was paid for the grant of the 2023 PSP Award which is structured as a nil cost option, and which shall ordinarily vest and become exercisable by Mr Jehle, subject to the satisfaction of the performance conditions set by the Remuneration Committee of the Company which are based on (i) the compound annual growth rate of the Group's adjusted diluted earnings per share ('EPS'), commencing on 1 January 2023 and ending on 31 December 2025 (the 'Performance Period') and (ii) the compound annual growth rate of the Group's Services Revenue over the Performance Period. The 2023 PSP Award is expected to vest in March 2026 and will be subject to a two-year holding period following vesting. The vested 2023 PSP Award held during the holding period will include the right to receive dividend equivalents as shares.

Replacement PSP Award

Director

Number of shares awarded2

Mr M C Jehle (Director)

13,527

2 Calculated using a price of (i) 2771 pence per Experian plc ordinary share, which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, for the 30 days to and including 31 May 2023, and (ii) 2379 pence per Computacenter plc ordinary share, which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, for the 30 days to and including 31 May 2023.

 

This Replacement PSP Award was granted to compensate Mr Jehle for performance-based awards forfeited by him as a result of leaving Experian (the 'Original PSP Awards'). In determining the structure of the Replacement PSP Award, the form of award, time horizon and extent to which performance conditions applied to the Original PSP Awards, was considered. The value of the Replacement PSP Award is equal to the Original PSP Awards, based on the price of an Experian plc ordinary share and a Computacenter plc ordinary share over a 30 day period, as set out directly above.

 

No consideration was paid for the grant of this Replacement PSP Award which is structured as a nil cost option over Ordinary Shares, and which shall ordinarily vest and become exercisable by Mr Jehle, subject to the satisfaction of the performance conditions set by the Remuneration Committee of the Company which are based on (i) the compound annual growth rate of the Group's adjusted diluted earnings per share ('EPS'), commencing on 1 January 2022 and ending on 31 December 2024 (the 'Performance Period') and (ii) the compound annual growth rate of the Group's Services Revenue over the Performance Period. The Replacement PSP Award is not subject to a holding period following vesting on 5 June 2025 (which is on or around the date of vesting of the Original PSP Awards had they not been forfeited).

 

All of the PSP Awards will be subject to malus and clawback provisions, and will be satisfied out of shares held by the 2011 Computacenter Employee Benefit Trust, or by new issue or treasury shares held by the Company at the discretion of the Board of the Company.

 

Grant of Awards - Replacement RSU Award

 

The Company announces that on 5 June 2023, the Company granted the following award over Ordinary Shares to the following Director and PDMR:

 

Director

Number of shares awarded3

Mr M C Jehle (Director)

5,695

3 Calculated using a price of (i) 2771 pence per Experian plc ordinary share, which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, for the 30 days to and including 31 May 2023, and (ii) 2379 pence per Computacenter plc ordinary share, which is the average middle market closing quotation, as derived from the Daily Official List of the London Stock Exchange, for the 30 days to and including 31 May 2023.

 

This award was granted to compensate Mr Jehle for service-based awards forfeited by him as a result of leaving Experian (the 'Original RSU Awards'). In determining the structure of the replacement award, the form of award, time horizon and extent to which performance conditions applied to the Original RSU Awards, was considered. The value of the replacement award (the 'Replacement RSU Award') is equal to that of the Original RSU Awards, based on the price of an Experian plc ordinary share and a Computacenter plc ordinary share over a 30 day period, as set out below.

 

The Replacement RSU Award is being granted to Mr Jehle under Listing Rule 9.4.2 as an arrangement established specifically to facilitate, in unusual circumstances, the recruitment of a director. Broadly the terms of the Computacenter 2017 Deferred Bonus plan will be applied, save that rule 5 (reduction of awards and clawback), rule 9 (cessation of employment) and rule 12 (amendments) will not apply, and the award may only be settled with market purchase shares.

 

No consideration was paid for the grant of the Replacement RSU Award, which is structured as a nil-cost option. There are no performance conditions or performance period that apply to the award, and it will vest in Mr Jehle on 1 July 2025 (which is on or around the same date of vesting of the Original RSU Award, had it not been forfeited). However, if prior to 1 July 2023, the Company: (i) terminates Mr Jehle's employment agreement in limited fault-based circumstances, or (ii) he resigns prior to that time, then the Replacement RSU Award will lapse in full.

 

PDMR/PCA FCA Transaction Notification

 

 

1.

 

 

Details of Person Discharging Managerial Responsibilities

 

 

 

 

Name

 

Marcus Christian Jehle

 

2.

 

Reason for the notification

 

 

2(a)

 

 

Position/Status

 

Chief Financial Officer

 

2(b)

 

 

Initial Notification/

Amendment

 

 

Initial Notification

 

3.

 

 

Details of the issuer

 

 

3(a)

 

 

Name

 

Computacenter plc

 

3(b)

 

 

LEI

 

549300XSXUZ1I19DB105

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Grant of a nil-cost option award over Ordinary Shares under the Computacenter Performance Share Plan 2005 (the '2023 PSP Award'). There is no price payable on the grant, vesting or exercise of the 2023 PSP Award. Vesting of the 2023 PSP Award is subject to the achievement of a performance condition over a three-year period from 1 January 2023 to 31 December 2025.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

33,973

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

33,973

 

4(e)

 

 

Date of the transaction

 

 

2023-6-05

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Grant of a nil-cost option award over Ordinary Shares under the Computacenter Performance Share Plan 2005 (the 'Replacement PSP Award'). There is no price payable on the grant, vesting or exercise of the Replacement PSP Award. Vesting of the Replacement PSP Award is subject to the achievement of a performance condition over a three-year period from 1 January 2022 to 31 December 2024.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

13,527

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

13,527

 

4(e)

 

 

Date of the transaction

 

 

2023-6-05

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Grant of a nil-cost option award over Ordinary Shares under Listing Rule 9.4.2 (the 'Replacement RSU Award'). There is no price payable on the grant, vesting or exercise of the Replacement RSU Award. There are no performance conditions which apply to the Replacement RSU Award.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

5,695

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

5,695

 

4(e)

 

 

Date of the transaction

 

 

2023-6-05

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue.

 

 

 

Enquiries:

 

Name:

Simon Pereira

Company Secretary

Address:

Computacenter plc

Hatfield Avenue

Hatfield

Hertfordshire

AL10 9TW

Telephone:

+44 (0) 7385 514 715

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEKXEDADEFA
Date   Source Headline
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM
23rd Mar 20224:45 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results 2021
7th Feb 20229:49 amRNSBlock listing Interim Review
24th Jan 20227:00 amRNSPre-Close Trading Statement
12th Jan 20229:45 amRNSHolding(s) in Company
14th Dec 20214:45 pmRNSHolding(s) in Company
13th Dec 20215:00 pmRNSHolding(s) in Company
10th Dec 20212:00 pmRNSCompany Secretary Change
2nd Dec 20212:45 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSQ3 2021 Trading Update
30th Sep 202112:00 pmRNSDirectorate Change
15th Sep 20214:25 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTrading Statement
12th Aug 202112:00 pmRNSDirector Declaration
6th Aug 202111:15 amRNSBlock listing Interim Review
21st Jul 20217:00 amRNSTrading Statement
20th May 20211:00 pmRNSResult of AGM
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSQ1 2021 Trading Update
20th Apr 20217:00 amRNS2020 Annual Report & Notice of 2021 AGM
24th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results 2020
10th Mar 20217:00 amRNSDirectorate Change
5th Feb 20211:18 pmRNSBlock listing Interim Review
25th Jan 202111:45 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSPre-Close Trading Statement
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSTrading Statement
10th Nov 20204:00 pmRNSPDMR/PCA Shareholding
30th Oct 20207:00 amRNSQ3 2020 Trading Update
27th Oct 20209:30 amRNSDirector/PDMR Shareholding
23rd Oct 20205:45 pmRNSApproval of Arrangement Agreement
16th Sep 202012:45 pmRNSDirector/PDMR Shareholding
15th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.